You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

ID: GL-END MOTAC 5 aoû 2017
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
H. Feilotter, D. Sivajohanathan, T. Graham, V.M. Siu, M. Speevak, T. Stockley, Molecular Oncology and Testing Advisory Committee

Guideline Objective

The Molecular Oncology and Testing Advisory Committee of Cancer Care Ontario endorses the recommendations of Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, published by the American College of Medical Genetics and Genomics (ACMG) regarding inherited cancers, as modified by the endorsement process described in this document.

This endorsement project was sponsored by MOTAC. The endorsed guideline will be used for the interpretation of sequence variants.

Intended Guideline Users

This guideline is intended for molecular geneticists, clinical geneticists, molecular pathologists and genetic counsellors across the province.

pdf download Full Report (PDF) (251.12 Ko)